Executive Team
Board of Directors
Board Committees
| Independent Directors | Audit | Compensation | Nominating and Corporate Governance |
|---|---|---|---|
|
Eric J. Ende, M.D., M.B.A |
|
||
|
Herbert Conrad |
|
|
|
|
James S. Scibetta |
|
|
|
|
Matthew A. Wikler, M.D., M.B.A., F.I.D.S.A. |
|
||
|
Natasha Giordano |
|
|
|
|
Kathryn Penkus Corzo |
|
|
Chair
Member
Scientific Advisory Board
Prof. Oliver Cornely, M.D., FACP, FIDSA
Professor of Internal Medicine and Attending Physician, Uniklinik Köln
Dimitrios P. Kontoyiannis, M.D., M.S., Sc.D., PhD (Hon),FACP, FIDSA, FECMM
Professor in the Department of Infectious Diseases Infection Control and Employee Health, The University of Texas
Peter G. Pappas, M.D., FACP
Professor of Medicine, University of Alabama
David S. Perlin, Ph.D.
Executive Director, New Jersey Medical School (NJMS), Rutgers Biomedical and Health Sciences
Infectious Disease Experts - MAT2501
Charles L. Daley, M.D.
Chief, Division of Mycobacterial & Respiratory Infections at National Jewish Health
Patrick A. Flume, M.D.
Director, Adult Cystic Fibrosis Center at Medical University of South Carolina
Donald VanDevanter, Ph.D.
Adjunct Professor of Pediatrics at Case Western Reserve University School of Medicine